MX7623E - Procedimiento para la preparacion de 4-amino-5-alquil-sulfonil-orto-anisamidas - Google Patents

Procedimiento para la preparacion de 4-amino-5-alquil-sulfonil-orto-anisamidas

Info

Publication number
MX7623E
MX7623E MX7911208U MX1120879U MX7623E MX 7623 E MX7623 E MX 7623E MX 7911208 U MX7911208 U MX 7911208U MX 1120879 U MX1120879 U MX 1120879U MX 7623 E MX7623 E MX 7623E
Authority
MX
Mexico
Prior art keywords
anisamides
orto
sulfonyl
amino
alkyl
Prior art date
Application number
MX7911208U
Other languages
English (en)
Spanish (es)
Inventor
Michel Thominet
Jacques Acher
Jean-Claude Monier
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of MX7623E publication Critical patent/MX7623E/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
MX7911208U 1978-01-20 1979-01-19 Procedimiento para la preparacion de 4-amino-5-alquil-sulfonil-orto-anisamidas MX7623E (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7801632A FR2415099A1 (fr) 1978-01-20 1978-01-20 Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes

Publications (1)

Publication Number Publication Date
MX7623E true MX7623E (es) 1990-03-27

Family

ID=9203689

Family Applications (2)

Application Number Title Priority Date Filing Date
MX7911208U MX7623E (es) 1978-01-20 1979-01-19 Procedimiento para la preparacion de 4-amino-5-alquil-sulfonil-orto-anisamidas
MX797669U MX5793E (es) 1978-01-20 1979-01-19 Procedimiento para la preparacion de 4-amino-5-alquilsulfonil-orto-anisamidas

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX797669U MX5793E (es) 1978-01-20 1979-01-19 Procedimiento para la preparacion de 4-amino-5-alquilsulfonil-orto-anisamidas

Country Status (42)

Country Link
US (2) US4294828A (pt-PT)
JP (1) JPS6049192B2 (pt-PT)
AR (2) AR221354A1 (pt-PT)
AT (1) AT377977B (pt-PT)
AU (1) AU528561B2 (pt-PT)
BE (1) BE872585A (pt-PT)
BG (2) BG31496A3 (pt-PT)
CA (1) CA1101430A (pt-PT)
CH (1) CH637927A5 (pt-PT)
CS (1) CS226181B2 (pt-PT)
CY (1) CY1201A (pt-PT)
DD (1) DD141520A5 (pt-PT)
DE (1) DE2901181C2 (pt-PT)
DK (1) DK158346C (pt-PT)
EG (1) EG14045A (pt-PT)
ES (2) ES476755A1 (pt-PT)
FI (1) FI71126C (pt-PT)
FR (1) FR2415099A1 (pt-PT)
GB (2) GB2083458B (pt-PT)
GR (1) GR64431B (pt-PT)
HK (1) HK12184A (pt-PT)
HU (1) HU179793B (pt-PT)
IE (1) IE47798B1 (pt-PT)
IL (1) IL56411A (pt-PT)
IN (1) IN150226B (pt-PT)
IT (1) IT1164655B (pt-PT)
LU (1) LU80786A1 (pt-PT)
MC (1) MC1232A1 (pt-PT)
MX (2) MX7623E (pt-PT)
NL (1) NL191707C (pt-PT)
NO (1) NO151320C (pt-PT)
NZ (1) NZ189378A (pt-PT)
OA (1) OA06156A (pt-PT)
PH (2) PH15725A (pt-PT)
PL (2) PL116532B1 (pt-PT)
PT (1) PT69068A (pt-PT)
RO (2) RO76393A (pt-PT)
SE (2) SE448874B (pt-PT)
SU (1) SU820659A3 (pt-PT)
YU (2) YU42172B (pt-PT)
ZA (1) ZA79219B (pt-PT)
ZM (1) ZM579A1 (pt-PT)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2440946A2 (fr) * 1978-01-20 1980-06-06 Ile De France Nouveaux benzamides heterocycliques substitues, leurs procedes de preparation et leur application comme modificateurs du comportement
ZA818221B (en) * 1980-12-12 1982-10-27 Beecham Group Plc Pharmaceutical compounds
FR2550447B1 (fr) * 1983-08-10 1986-01-17 Ile De France Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire
FR2574795B1 (fr) * 1984-12-18 1987-11-20 Ile De France Nouveau procede industriel de synthese du n-((1'-allyl 2'-pyrrolidinyl) methyl) 2-methoxy 4,5-azimido benzamide
FR2584401B1 (fr) * 1985-07-04 1987-11-20 Ile De France Nouveau benzamide, son procede de preparation et son application dans le domaine therapeutique
US5227388A (en) * 1989-12-26 1993-07-13 Hoechst-Roussel Pharmaceuticals Incorporated Thienobenzoxepins and naphthothiophenes
US5260319A (en) * 1989-12-26 1993-11-09 Hoechst-Roussel Pharmaceuticals Incorporated Thienobenzoxepins and naphthothiophenes
FR2678266A1 (fr) * 1991-06-28 1992-12-31 Delagrange Laboratoires Nouveaux derives de 2-hydroxy 4-amino 5-ethylsulfonyl benzamide utiles comme anxiolytiques.
FR2699533A1 (fr) * 1992-12-21 1994-06-24 Mouhtaram Mohamed Dérivés de N-((1,4-dialkyl-6-arylpipérazine-2-yl)méthyl)benzamides. (Isomères cis et trans) Propriétés pharmacologiques et applications.
FR2753376B1 (fr) * 1996-09-18 1998-10-16 Synthelabo Compositions pharmaceutiques comprenant de l'amisulpride et leurs applications therapeutiques
FR2762213B1 (fr) * 1997-04-18 1999-05-14 Synthelabo Composition pharmaceutique a retention gastrique
US6169094B1 (en) * 1998-07-14 2001-01-02 Sanofi-Synthelabo Compositions of (S) (-)-amisulpride
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
JP2006528676A (ja) * 2003-05-16 2006-12-21 ファイザー・プロダクツ・インク 非定形型抗精神病薬と、ｇａｂａ調節薬及び／又は抗痙攣薬の治療上の組合せ
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
MXPA06013163A (es) * 2004-05-11 2007-02-13 Pfizer Prod Inc Combinacion de antipsicoticos atipicos y antagonistas del receptor 5-ht1b.
MX2007013026A (es) * 2005-04-22 2008-01-11 Wyeth Corp Combinaciones terapeuticas para el tratamiento o prevencion de trastornos psicoticos.
EP1889198B1 (en) 2005-04-28 2014-11-26 Proteus Digital Health, Inc. Pharma-informatics system
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
US7825156B2 (en) * 2007-02-02 2010-11-02 Copharms Method of treating bipolar depression with a benzamide derivative
WO2009156889A1 (en) * 2008-06-25 2009-12-30 Pfizer Inc. Diaryl compounds and uses thereof
US20100105755A1 (en) * 2008-09-12 2010-04-29 Auspex Pharmaceuticals, Inc. Substituted benzamide modulators of dopamine receptor
DK3395372T3 (da) 2009-02-20 2022-04-19 Enhanx Biopharm Inc System til afgivelse af glutathion-baseret medikament
EP2427178B1 (en) 2009-05-06 2023-01-04 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
CN101898991B (zh) * 2009-05-31 2013-09-25 江苏天士力帝益药业有限公司 一种(s)(-)-氨磺必利d-(-)-酒石酸盐的合成方法
CN101628886B (zh) * 2009-08-25 2012-12-12 北京紫萌同达科技有限公司 一种2-甲氧基-4-氨基-5-乙砜基苯甲酸的合成方法
AU2014202535B2 (en) * 2010-03-11 2016-05-26 Acacia Pharma Limited The use of amisulpride as an anti-emetic
AU2016216578B2 (en) * 2010-03-11 2017-11-23 Acacia Pharma Limited The use of amisulpride as an anti-emetic
GB201004020D0 (en) * 2010-03-11 2010-04-21 Acacia Pharma Ltd New therapeutic use
MX2012014497A (es) 2010-06-17 2013-04-03 Lupin Ltd Un proceso mejorado para la preparación de amilsuprida.
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN103304453A (zh) * 2013-06-18 2013-09-18 苏州诚和医药化学有限公司 两步法合成2-甲氧基-4-氨基-5-乙砜基苯甲酸
CN103319384A (zh) * 2013-06-18 2013-09-25 苏州诚和医药化学有限公司 制备2-甲氧基-4-氨基-5-乙砜基苯甲酸的方法
CN103450058B (zh) * 2013-09-18 2015-10-14 广安凯特医药化工有限公司 一种氨磺必利酸的制备方法
CN104725292B (zh) * 2015-03-23 2017-07-25 湖北荆江源制药股份有限公司 一种(s)(‑)‑氨磺必利的制备方法
GB201618425D0 (en) * 2016-11-01 2016-12-14 Acacia Pharma Ltd method
US11377421B2 (en) 2016-11-28 2022-07-05 Lb Pharmaceuticals Inc. Psychotropic agents and uses thereof
AU2017364899B2 (en) 2016-11-28 2023-07-06 Lb Pharmaceuticals Inc. Psychotropic agents and uses thereof
CN106995397B (zh) * 2016-12-12 2020-01-14 河北医科大学 R-氨磺必利药用盐、制备方法、晶型及其用途
GB201702250D0 (en) 2017-02-10 2017-03-29 Acacia Pharma Ltd Method
WO2019113084A1 (en) 2017-12-05 2019-06-13 Sunovion Pharmaceuticals Inc. Crystal forms and production methods thereof
SG11202005016SA (en) 2017-12-05 2020-06-29 Sunovion Pharmaceuticals Inc Nonracemic mixtures and uses thereof
CN110790693A (zh) * 2018-08-02 2020-02-14 北京万全德众医药生物技术有限公司 一种(s)(-)-氨磺必利的制备方法
KR20220018004A (ko) 2019-06-04 2022-02-14 선오비온 파마슈티컬스 인코포레이티드 조절 방출 제형 및 이의 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR2313935A1 (fr) * 1975-06-10 1977-01-07 Ile De France Nouveaux benzamides substitues, leurs derives et leur procede de preparation
US3862139A (en) * 1972-06-23 1975-01-21 Delmar Chem Heterocyclic benzamide compounds
FR2244760B1 (pt-PT) * 1973-09-25 1980-06-27 Ile De France
FR2299862B1 (fr) * 1975-02-07 1978-07-21 Ile De France Nouveau
FR2294698A1 (fr) * 1974-12-18 1976-07-16 Synthelabo Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment
CA1039731A (en) * 1974-12-18 1978-10-03 Synthelabo Process for preparing new 2-methoxy-benzamide derivatives

Also Published As

Publication number Publication date
DK158346C (da) 1990-10-08
GR64431B (en) 1980-03-21
DD141520A5 (de) 1980-05-07
AR221354A1 (es) 1981-01-30
SU820659A3 (ru) 1981-04-07
NO151320B (no) 1984-12-10
DE2901181C2 (de) 1984-07-19
NL7900457A (nl) 1979-07-24
CS226181B2 (en) 1984-03-19
US4294828A (en) 1981-10-13
IN150226B (pt-PT) 1982-08-21
AT377977B (de) 1985-05-28
IE47798B1 (en) 1984-06-27
BG31496A3 (en) 1982-01-15
ES477782A1 (es) 1979-09-16
AU528561B2 (en) 1983-05-05
IL56411A0 (en) 1979-03-12
DK158346B (da) 1990-05-07
SE448874B (sv) 1987-03-23
GB2012765A (en) 1979-08-01
EG14045A (en) 1983-09-30
CA1101430A (en) 1981-05-19
ZA79219B (en) 1980-01-30
IT7947706A0 (it) 1979-01-18
ES476755A1 (es) 1979-06-01
SE8603773D0 (sv) 1986-09-09
NL191707B (nl) 1995-12-01
FR2415099A1 (fr) 1979-08-17
NO151320C (no) 1985-04-17
BG31497A3 (en) 1982-01-15
IE790092L (en) 1979-07-20
DK20979A (da) 1979-07-21
YU25483A (en) 1983-10-31
ATA39879A (de) 1983-12-15
PL116532B1 (en) 1981-06-30
NL191707C (nl) 1996-04-02
US4401822A (en) 1983-08-30
AU4337379A (en) 1979-07-26
HU179793B (en) 1982-12-28
CH637927A5 (fr) 1983-08-31
JPS54145658A (en) 1979-11-14
YU5079A (en) 1983-06-30
IT1164655B (it) 1987-04-15
IL56411A (en) 1982-09-30
YU41278B (en) 1986-12-31
AR220574A1 (es) 1980-11-14
RO80311A (ro) 1982-12-06
YU42172B (en) 1988-06-30
PL212899A1 (pt-PT) 1980-01-14
NZ189378A (en) 1983-03-15
FI71126C (fi) 1986-11-24
GB2083458A (en) 1982-03-24
FI790182A (fi) 1979-07-21
HK12184A (en) 1984-02-24
FI71126B (fi) 1986-08-14
CY1201A (en) 1983-12-31
MX5793E (es) 1984-07-19
PH15725A (en) 1983-03-18
MC1232A1 (fr) 1979-10-26
SE460968B (sv) 1989-12-11
JPS6049192B2 (ja) 1985-10-31
LU80786A1 (fr) 1979-09-07
NO790180L (no) 1979-07-23
PL118151B1 (en) 1981-09-30
GB2012765B (en) 1982-09-08
FR2415099B1 (pt-PT) 1981-02-20
PT69068A (fr) 1979-02-01
OA06156A (fr) 1981-06-30
DE2901181A1 (de) 1979-07-26
RO76393A (ro) 1981-03-30
SE7900380L (sv) 1979-07-21
GB2083458B (en) 1983-03-09
BE872585A (fr) 1979-06-07
PH22287A (en) 1988-07-22
ZM579A1 (en) 1979-12-21
SE8603773L (sv) 1986-09-09

Similar Documents

Publication Publication Date Title
MX5631E (es) Procedimiento para la preparacion de acil-anilinas
MX5793E (es) Procedimiento para la preparacion de 4-amino-5-alquilsulfonil-orto-anisamidas
ES481909A0 (es) Procedimiento para la preparacion de nuevas aril-3 eter-5 o-xazolidinonas-2
MX6749E (es) Procedimiento para la preparacion de derivados de tetrazolilalcoxicarboestirilo
ES482499A0 (es) Procedimiento para la preparacion de 2-cloro-6-nitroanilinas
ES494634A0 (es) Procedimiento para la preparacion de compuestos de cefem y cefam
MX7633E (es) Procedimiento para la preparacion de compuestos de difenileter
AR221428A1 (es) Procedimiento para la preparacion de derivados de pirrolidinil-y de pirrolidinilmetil-benzamidas
AR227379A1 (es) Procedimiento para la preparacion de 1-aril-2-imidazolil vinileteres
MX5509E (es) Procedimiento para la preparacion de n-halogenoacetil-fenilaminocarboniloximas
MX5898E (es) Procedimiento para la preparacion de 2-amino-4-pirimidonas
AR224784A1 (es) Procedimiento para la preparacion de nuevos derivados de 4-amino-2-piperidinoquinazolina
ES485567A0 (es) Procedimiento para la preparacion de azolilcetales
MX5594E (es) Procedimiento mejorado para la preparacion de derivados de n-trifluoroacetil-n-fosfonometilglicinatos
MX5909E (es) Procedimiento mejorado para la preparacion de ciclohexanona
ES484342A0 (es) Procedimiento para la preparacion de propenilensulfona
MX149694A (es) Procedimiento para la preparacion de trialcoxisilanos de fenoxialquilo
MX6232E (es) Procedimiento para la preparacion de auronas substituidas
MX5955E (es) Procedimiento para la preparacion de derivados de piridoxina
MX5605E (es) Procedimiento mejorado para la preparacion de 2-isopropilaminopirimidina
ES490200A0 (es) Procedimiento mejorado para la preparacion de sulfonilureas
MX5445E (es) Procedimiento para la preparacion de derivados de isotiocianobenzotiazol
MX5674E (es) Procedimiento para la preparacion de derivados de la butenofenona
MX5913E (es) Procedimiento mejorado para la preparacion de triciclazol
AR228723A1 (es) Procedimiento para la preparacion de 2-cloro-4-etilamino-6-isopropilamino-s-triazina